catalyx space | $5,400,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025) Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)